High prevalence of relapse in children with Philadelphia-like acute lymphoblastic leukemia despite risk-adapted treatment

Affiliations

• ¹ Cancer Theme, South Australian Health & Medical Research Institute (SAHMRI), Adelaide, SA, Australia.
• ² Discipline of Medicine, University of Adelaide, SA, Australia.
• ³ Australian and New Zealand Children's Haematology/Oncology Group (ANZCHOG), Australia.
• ⁴ Molecular Diagnostics, Children's Cancer Institute, Sydney, NSW, Australia.
• ⁵ Genetics and Molecular Pathology, SA Pathology, Adelaide, SA, Australia.
• ⁶ Sydney Children's Hospital Network, Sydney, NSW, Australia.
• ⁷ Women's & Children's Hospital, Adelaide, SA, Australia.
• ⁸ Australian Genomic Health Alliance (AGHA), Australia.
• ⁹ Oncology Services Group, Children's Health Queensland Hospital and Health Service, Brisbane, QLD, Australia.
• ¹⁰ The University of Queensland Diamantina Institute and UQ Child Health Research Centre, The University of Queensland, Brisbane, QLD, Australia.
• ¹¹ Mater Children's Hospital Brisbane, QLD, Australia.
• ¹² John Hunter Children's Hospital, Newcastle, NSW, Australia.
• ¹³ Division of Haematology, SA Pathology, Adelaide, SA, Australia.
• ¹⁴ Department of Pathology, St Jude Children's Research Hospital, Memphis, TN, USA.
• ¹⁵ School of Women and Children's Health, University of New South Wales, Sydney, NSW, Australia.
• ¹⁶ Cancer Theme, South Australian Health & Medical Research Institute (SAHMRI), Adelaide, SA, Australia deborah.white@sahmri.com.
• ¹⁷ Discipline of Paediatrics, University of Adelaide, SA, Australia.